FORMATION OF AN INACTIVE CYTOCHROME-P-450 FE(II)-METABOLITE COMPLEX AFTER ADMINISTRATION OF TROLEANDOMYCIN IN HUMANS

被引:106
作者
PESSAYRE, D
LARREY, D
VITAUX, J
BREIL, P
BELGHITI, J
BENHAMOU, JP
机构
关键词
D O I
10.1016/0006-2952(82)90671-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1699 / 1704
页数:6
相关论文
共 18 条
[1]   POSSIBLE WARFARIN-ERYTHROMYCIN INTERACTION [J].
BARTLE, WR .
ARCHIVES OF INTERNAL MEDICINE, 1980, 140 (07) :985-987
[2]  
BRODIE BB, 1949, J BIOL CHEM, V179, P25
[3]  
CUMMINS LH, 1977, PEDIATRICS, V59, P144
[4]  
DANAN G, 1981, J PHARMACOL EXP THER, V218, P509
[5]  
DRAVET C, 1977, LANCET, V1, P810
[6]   INHIBITION OF MIXED-FUNCTION OXIDATIONS BY SUBSTRATES FORMING REDUCED CYTOCHROME-P-450 METABOLIC-INTERMEDIATE COMPLEXES [J].
FRANKLIN, MR .
PHARMACOLOGY & THERAPEUTICS PART A-CHEMOTHERAPY TOXICOLOGY AND METABOLIC INHIBITORS, 1977, 2 (01) :227-245
[7]  
Hayton A C, 1969, N Z Med J, V69, P42
[8]  
HINTON NORMAN A., 1959, ANTIBIOT AND CHEMOTHER, V9, P667
[9]  
LAGIER G, 1979, THERAPIE, V34, P515
[10]  
LEDAFNIET M, 1981, J PHARMACOL EXP THER, V219, P558